Oral BHB and 5-HTP Composition for Snoring and Sleep Apnea

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current remedies for snoring and sleep apnea are often uncomfortable or invasive and do not address the root causes of these conditions, leading to disrupted sleep and overall health issues.

Innovation Solution

A composition comprising Magnesium beta-hydroxybutyrate (BHB), Calcium beta-hydroxybutyrate (BHB), Sodium beta-hydroxybutyrate (BHB), and 5-Hydroxytryptophan (5-HTP) is blended in a specific order and used orally to target respiratory and muscular systems, providing a non-invasive solution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current remedies (devices or invasive procedures) are used to prevent snoring and sleep apnea, then the symptoms may be addressed, but the remedies are uncomfortable and invasive, reducing quality of life

Engineering Contradiction:
Improveeffectiveness in preventing snoring and sleep apneaVSAvoidcomfort and non-invasive nature
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent replaces mechanical devices (such as CPAP machines, mouthguards, or surgical procedures) with a natural supplement composition containing Magnesium BHB, Calcium BHB, Sodium BHB, and 5-HTP. This substitution eliminates the need for uncomfortable mechanical equipment or invasive procedures while aiming to achieve the same therapeutic effect through biochemical mechanisms that relax muscles and improve respiratory function naturally.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If current remedies are used, then snoring and sleep apnea may be managed, but they do not target the root causes, leading to disrupted sleep and health issues

Engineering Contradiction:
Improveeffectiveness in managing sleep disordersVSAvoidsleep disruption and time lost to poor sleep quality
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent employs preliminary action by taking the supplement composition before bedtime, allowing the active ingredients to begin working during the evening and night. Magnesium BHB, Calcium BHB, and Sodium BHB start relaxing muscles and improving respiratory function in advance, while 5-HTP prepares the nervous system for better sleep. This timing ensures that the root causes are addressed before sleep disruption occurs, rather than managing symptoms after they manifest.

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If the composition is taken orally to target respiratory and muscular systems, then a non-invasive solution is provided, but the formulation and blending process requires precision

Engineering Contradiction:
Improvenon-invasive oral administrationVSAvoidblending order and speed control
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The patent applies segmentation by dividing the blending process into distinct sequential steps, with each ingredient added in a specific order at controlled speeds. The process segments the mixing operation into: (1) adding Magnesium BHB at low speed, (2) adding Calcium BHB at low speed, (3) adding Sodium BHB at low speed, and (4) adding 5-HTP at low speed. This segmentation ensures proper distribution and prevents premature aggregation of ingredients, maintaining manufacturing precision while enabling non-invasive oral delivery.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20260021063A1Compositions for facilitating prevention of snoring and sleep apnea
Publication Date: 2026.01.22 GLASER DENNIS
  • US20260021063A1 patent drawing
  • US20260021063A1 patent drawing
  • US20260021063A1 patent drawing

AI summary

The present invention provides a composition, a method of making the composition, and a method of using such composition for facilitating prevention of snoring and sleep apnea. The disclosed composition includes at least one active ingredient selected from Magnesium BHB, Calcium BHB, Sodium BHB, or 5-Hydroxytryptophan. According to an exemplary embodiment of the present invention, Silentium, which comprises one of the disclosed compositions, stops snoring and cures sleep apnea. The composition may be prepared by first adding and blending Magnesium BHB, then Calcium BHB, then Sodium BHB, and lastly, 5-Hydroxytryptophan. The composition may be taken orally in the form of a capsule or in the form of a solution.